G.R. SMITH, Magistrate Judge.
Before the Court is the latest round in the dispute over the deposition of Betty Riner. Plaintiffs moved to compel her testimony. Doc. 125. Riner responded that she was "willing and eager to fully comply with her obligation to give full and truthful testimony," but expressed concern that her testimony would subject her to liability under an (otherwise unrelated) settlement agreement between her and defendant Corizon Health. Doc. 130 at 8 (emphasis added). Corizon also opposed plaintiff's motion, contending Riner's testimony was both precluded by the settlement agreement and irrelevant. Doc. 131. The Court directed the parties to confer and try to formulate a protective order that would assuage Riner's liability concerns, protect Corizon's bargained-for confidentiality, and allow plaintiffs to take Riner's testimony. Doc. 141.
The Court's hopes for a negotiated, mutually-agreeable solution have not borne fruit. Corizon now moves for a protective order. Doc. 145. Plaintiffs seek an order compelling Riner to testify, without any restriction, and awarding fees from Riner's counsel and Corizon "as a sanction for their conduct at the first deposition — and now for Corizon's conduct during the meet-and-confer period." Doc. 146 at 14; doc. 156. Riner, for her part, asks the Court to issue a protective order excusing her from testifying, now contending that her testimony is irrelevant and cumulative, see doc. 151 at 5, and if the Court declines her request, for "topic-specific guidance as to exactly what she must testify about pursuant to Plaintiffs' subpoena or a Court order and provide [her with] protection from suit or liability instigated by Corizon under the confidential Settlement Agreement related to any testimony she might provide." Id. at 11. Naturally, both Corizon and Riner oppose any award of fees or the imposition of sanctions. See doc. 131 (Corizon's opposition to plaintiffs' original motion requesting it be denied "in its entirety"); doc. 151 at 11.
As the Court's last Order explained, the private agreement between Riner and Corizon
Under the Federal Rules, permissible discovery depends upon relevance.
Even if a party establishes that challenged discovery is relevant, the Court may nevertheless disallow or limit it. See, e.g., Fed. R. Civ. P. 45(d)(3). The Federal Rules specifically direct courts to consider, among other factors affecting the scope of discovery, "whether the burden or expense of the proposed discovery outweighs its likely benefit." Fed. R. Civ. P. 26(b)(1). Riner contends that the burden imposed by her testifying, subject to the risk of litigation or liability, overwhelms its likely benefit. See doc. 151 at 7 ("[T]he nature of the testimony [Riner] is capable of providing does not justify the burden that testifying in this case places upon her, nor does it justify the jeopardy that testifying would subject her to."); see also doc. 145 at 6 ("Corizon Health simply cannot say in advance that Ms. Riner will not be in breach of the settlement agreement [if she testifies] or that a breach, should it occur, will be consequence-free."). Plaintiffs have cited nothing that suggests such burdens should not be weighed in the balancing the Rules require.
The difficulty the Court faces, then, is to balance the risk that Riner faces from testifying (slim as that may be) against the unknown value of testimony she has not yet provided. Rather than attempt to count the angels dancing on that pinhead, the Court will pursue a middle course. Plaintiffs and Corizon agree that a protective order would mitigate this difficulty, although they are unable to settle on terms amongst themselves. See doc. 145 at 6 (Corizon seeks an order sealing the deposition and only unsealing it "based on motion and after presentation of what information could and should be disseminated into the public record."); doc. 146-4 (plaintiffs' proposed order, including a 14-day period in which the transcript would remain sealed.) Given the Court's broad discretion in this area, it will impose some minimal constraints on the dissemination of Riner's testimony.
Plaintiffs and Corizon agree that some level of confidentiality for Riner's testimony will not undermine plaintiffs' interest in hearing her testimony and determining its value for themselves. Plaintiffs correctly point out that the stringent confidentiality measures Corizon proposes run afoul of the, law's general disfavor of secret judicial proceedings and records. See doc. 146 at 12; F.T.C. v. Abbvie Prods. LLC, 713 F.3d 54, 62 (11th Cir. 2013) ("The common-law right of access establishes a general presumption that criminal and civil actions should be conducted publicly. . . ." (quotes, alterations, and cite omitted)); see also, e.g., S.D. Ga. L. Civ. R. 79.7(d) (noting the "presumption of openness [of court records] is derived from the First Amendment"). Since the parties were unable to resolve this difficulty on their own, the Court will do it for them.
The parties, and any person privy to the substance of Riner's testimony, are
The Court, however, can neither provide Riner with a definitive interpretation of her agreement with Corizon nor indemnify her against suit. The Court may not issue advisory opinions. See, e.g., Thigpen v. Smith, 792 F.2d 1507, 1514 (11th Cir. 1986) (citation omitted) (Constitution's limitation of federal court's jurisdiction to "cases" and "controversies" implies that they "have no authority to issue advisory or hypothetical decisions."). Riner's request for an interpretation of her own agreement and "protection" against a hypothetical future suit by Corizon seeks nothing less. She doesn't provide any authority, beyond the Court's broad discretion to control discovery, suggesting the Court has the power to issue the order she's requested in the context of a discovery dispute.
Finally, the Court will not accede to plaintiffs' request to recover the fees they have incurred in this dispute from Riner's counsel and Corizon. See doc. 145 at 14-15. Although the Court cannot say that the parties' conduct has been entirely above reproach, it does appear that there is a sufficient "genuine dispute" that shifting expenses is not warranted. See, e.g., CHARLES ALAN WRIGHT, ARTHUR R. MILLER, et al. 8B FED. PRAC. & PROC. CIV. § 2288 (3d ed. 2017) ("Making a motion, or opposing a motion, is `substantially justified' if the motion raised an issue about which reasonable people could genuinely differ on whether a party was bound to comply with a discovery rule."). Despite the Court's ultimate agreement with plaintiffs that the Settlement Agreement could not preclude Riner's testimony, Riner and Corizon have shown that reasonable people might differ on whether that testimony should be subject to burden-limiting protections. That's enough, in the Court's discretion, to avoid fee shifting.
In summary, plaintiffs shall be allowed to subpoena Riner for a second deposition. See Fed. R. Civ. P. 30(a)(2)(A)(ii) (requiring leave of court before second deposition of the same deponent). Plaintiffs' various requests concerning Riner's deposition (docs. 125, 146, & 156) are
Finally, plaintiffs have expressed concern over the effect that the prolonged dispute over Riner's deposition has had on the schedule for completing discovery in this case. See doc. 156. To assuage that reasonable concern, the Court will proactively extend the close of expert discovery and the civil motions deadline by 30 days. Accordingly, the Court's scheduling Order (doc. 155) is amended as follows: